Nexalin Technology (NXL) Common Equity (2021 - 2026)

Nexalin Technology's Common Equity history runs 6 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Common Equity rose 24.12% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 24.12% YoY), while the FY2025 annual figure was $3.7 million, up 1.96% from the prior year.
• Common Equity was $2.9 million for Q1 2026 at Nexalin Technology, down from $3.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $6.4 million in Q3 2022 to a low of -$2.2 million in Q2 2022.
• Historically, Common Equity has averaged $3.2 million across 5 years, with a median of $3.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity surged 425.74% in 2022, then slumped 66.17% in 2024.
• A 5-year view of Common Equity shows it stood at $5.5 million in 2022, then tumbled by 41.47% to $3.2 million in 2023, then grew by 14.64% to $3.7 million in 2024, then increased by 1.96% to $3.7 million in 2025, then retreated by 22.99% to $2.9 million in 2026.
• The last three Common Equity figures came in at $2.9 million (Q1 2026), $3.7 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.